Phytochemicals for breast cancer therapy: current status and future implications

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• Breast cancer is a leading cause of cancer in women, with current treatments facing challenges like therapeutic resistance and recurrence.
• Cancer stem cells (CSCs) are implicated in drug resistance and tumor recurrence in breast cancer.
• Developing therapies that target both bulk tumor cells and CSCs is crucial for improved treatment outcomes.

Purpose of the Study:

• To review the current preclinical applications of phytochemicals, specifically flavonoids, in breast cancer therapy.
• To highlight the potential of phytochemicals in targeting both differentiated cancer cells and cancer stem cells (CSCs).
• To explore the development of novel breast cancer therapeutics derived from natural compounds.

Main Methods:

• Literature review of preclinical studies on phytochemicals, focusing on flavonoids, for breast cancer treatment.
• Analysis of the mechanisms by which phytochemicals affect breast cancer cells and CSCs.
• Evaluation of the potential for rational drug design based on natural flavonoid structures.

Main Results:

• Phytochemicals, especially flavonoids, demonstrate significant potential in preclinical breast cancer models.
• These compounds show efficacy against both general cancer cells and cancer stem cells (CSCs).
• Natural products offer a safer alternative or adjunct to conventional chemotherapy.

Conclusions:

• Phytochemicals, particularly flavonoids, represent a promising avenue for breast cancer therapy, addressing limitations of current treatments.
• Targeting CSCs with phytochemicals is a key strategy to overcome drug resistance and prevent recurrence.
• Further research and rational drug design based on potent natural molecules can lead to novel, effective breast cancer drugs.